Professor of Medicine, Temple University
Oncology
Dr. Lori A. Goldstein, MD
|
|
Give Review
Dr. Lori A. Goldstein works in the field of Oncology. She went to medical school at State University of New York Upstate Medical University. She over the years received 5 awards: "Philadelphia Magazine", "America's Top Doctors", "America's Top Doctors for Cancer", "Fellow (FASCO)" and "Redbook Magazine: Top Breast Cancer Doctors". Lori Goldstein is a published doctor as well. She has 40 publications published. The latest was: Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. Lori Goldstein accepts Medicare payments and is registered with Medicare.gov.
Publications
- Multifocal and Multicentric Breast Cancer is Associated with Increased Local Recurrence Regardless of Surgery Type.
- Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
- Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience.
- Risk of Positive Nonsentinel Nodes in Women with 1-2 Positive Sentinel Nodes Related to Age and Molecular Subtype Approximated by Receptor Status.
- Reducing the time from initial call to first appointment: the impact of patient access redesign and a nurse navigation program.
- How Do I Follow Patients With Early Breast Cancer After Completing Adjuvant Therapy.
- Breast Cancer, Version 3.2013.
- Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: Little evidence of improvement over the past 30 years.
- Identifying patients who may be candidates for a clinical trial of salvage accelerated partial breast irradiation after previous whole breast irradiation.
- Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer.
- Lymphatic Space Invasion is Not an Independent Predictor of Outcomes in Early Stage Breast Cancer Treated by Breast-Conserving Surgery and Radiation.
- Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer.
- Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study.
- Invasive breast cancer.
- Breast cancer: noninvasive and special situations.
- Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation.
- History of smoking is associated with younger age at diagnosis of breast cancer.
- Optimizing chemotherapy regimens for patients with early-stage breast cancer.
- Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.
- NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.
- Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary n...
- Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
- A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer.
- Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription po...
- Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer.
- NCCN Task Force Report: breast cancer in the older woman.
- Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners initiative.
- Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
- Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.
- Controversies in adjuvant endocrine treatment of premenopausal women.
- American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-posit...
- Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.
- Prognostic and predictive factors in early-stage breast cancer.
- Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older.
- American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.
- Taxanes in the adjuvant treatment of breast cancer.
- Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primar...
- American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast canc...
- Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer.
Doctors Specialties
- Psychiatry
- Oncology
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
- America's Top Doctors for Cancer
- Fellow (FASCO)
- Redbook Magazine: Top Breast Cancer Doctors
Education
-
National Institutes of Health Clinical Center -
University of Pittsburgh Medical Center -
State University of New York Upstate Medical University -
University of Pennsylvania
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Adam D. Cohen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Migliaccio, MD |
|
|
Dr. Chala A. Sargent, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil S. Schwalb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Giampaolo Gallo, MD |
|
|
Dr. Igor A. Astsaturov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi Amaravadi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alexander Kutikov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfred L. Garfall, MD
This Doctor is OpenDoctor Recommended.
|